BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15284771)

  • 1. A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervical examinations.
    Wing DA; Fassett MJ; Guberman C; Tran S; Parrish A; Guinn D
    Am J Obstet Gynecol; 2004 Jun; 190(6):1689-94; discussion 1694-6. PubMed ID: 15284771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labor induction with the prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial.
    Sanchez-Ramos L; Kaunitz AM; Del Valle GO; Delke I; Schroeder PA; Briones DK
    Obstet Gynecol; 1993 Mar; 81(3):332-6. PubMed ID: 8437780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction.
    Wing DA; Paul RH
    Am J Obstet Gynecol; 1996 Jul; 175(1):158-64. PubMed ID: 8694043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol: an effective agent for cervical ripening and labor induction.
    Wing DA; Rahall A; Jones MM; Goodwin TM; Paul RH
    Am J Obstet Gynecol; 1995 Jun; 172(6):1811-6. PubMed ID: 7778637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of misoprostol for labor induction: a randomized controlled trial.
    Windrim R; Bennett K; Mundle W; Young DC
    Obstet Gynecol; 1997 Mar; 89(3):392-7. PubMed ID: 9052592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices.
    Buser D; Mora G; Arias F
    Obstet Gynecol; 1997 Apr; 89(4):581-5. PubMed ID: 9083316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Misoprostol--a PGE1 analog for induction of labor at term: comparative and randomized study with oxytocin].
    Campos GA; Guzmán S; Rodríguez JG; Voto LS; Margulies M
    Rev Chil Obstet Ginecol; 1994; 59(3):190-5; discussion 195-6. PubMed ID: 7659811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of uterine activity. Using oxytocin after intracervical PGE2.
    Coleman FH; Rayburn WF; Burks LS; Farmer KC; Larson JD; Turnbull GL
    J Reprod Med; 1997 Jan; 42(1):44-8. PubMed ID: 9018645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol for cervical ripening and labor induction: a meta-analysis.
    Sanchez-Ramos L; Kaunitz AM; Wears RL; Delke I; Gaudier FL
    Obstet Gynecol; 1997 Apr; 89(4):633-42. PubMed ID: 9083326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trial of pulsatile versus continuous oxytocin administration for the induction of labor.
    Reid GJ; Helewa ME
    J Perinatol; 1995; 15(5):364-6; quiz 367-8. PubMed ID: 8576747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labor induction with continuous low-dose oxytocin infusion: a randomized trial.
    Mercer B; Pilgrim P; Sibai B
    Obstet Gynecol; 1991 May; 77(5):659-63. PubMed ID: 2014075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative trial of labor induction with misoprostol versus oxytocin.
    Escudero F; Contreras H
    Int J Gynaecol Obstet; 1997 May; 57(2):139-43. PubMed ID: 9184950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravenous oxytocin and vaginal prostaglandin E2 gel in women with unripe cervixes and premature rupture of the membranes.
    Ekman-Ordeberg G; Uldbjerg N; Ulmsten U
    Obstet Gynecol; 1985 Sep; 66(3):307-10. PubMed ID: 3860789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does prostaglandin confer significant advantage over oxytocin infusion for nulliparas with pre-labor rupture of membranes at term?
    Chua S; Arulkumaran S; Kurup A; Anandakumar C; Tay D; Ratnam SS
    Obstet Gynecol; 1991 May; 77(5):664-7. PubMed ID: 2014076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labor Induction Outcomes with Outpatient Misoprostol for Cervical Ripening among Low-Risk Women.
    Kandahari N; Schneider AN; Tucker LS; Raine-Bennett TR; Mohta VJ
    Am J Perinatol; 2024 May; 41(S 01):e818-e826. PubMed ID: 36130669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra uterine fetal death in Mulago Hospital, Uganda.
    Nakintu N
    Afr Health Sci; 2001 Dec; 1(2):55-9. PubMed ID: 12789117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intervals for increasing the dosage of oxytocin].
    Adelwöhrer NE; Rollett H; Haas J; Auner J
    Zentralbl Gynakol; 1993; 115(9):396-9. PubMed ID: 8237158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsatile administration enhances the effect and reduces the dose of oxytocin required for induction of labor.
    Randolph GW; Fuchs AR
    Am J Perinatol; 1989 Apr; 6(2):159-66. PubMed ID: 2712912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective comparison of hourly and quarter-hourly oxytocin dose increase intervals for the induction of labor at term.
    Blakemore KJ; Qin NG; Petrie RH; Paine LL
    Obstet Gynecol; 1990 May; 75(5):757-61. PubMed ID: 2325960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study.
    Sanchez-Ramos L; Chen AH; Kaunitz AM; Gaudier FL; Delke I
    Obstet Gynecol; 1997 Jun; 89(6):909-12. PubMed ID: 9170463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.